Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1082 of 5804
-
New hope for ITP patients: weekly shot may boost platelets when pills Don't work
Disease control Recruiting nowThis study is a prospective, multicenter, open-label, single-arm cohort study to evaluate the effectiveness and safety of romiplostim in patients with immune thrombocytopenia (ITP) who have not responded to oral thrombopoietin receptor agonists (TPO-RAs) such as eltrombopag, hetr…
Phase: NA • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Could a cancer drug ease rett syndrome? early trial launches
Disease control Recruiting nowThe RETT REVOLUTION trial is a placebo-controlled, single-blinded, exploratory study with patients serving as their own control ("N of 1" trial design) where the safety and efficacy of vorinostat in the treatment of Rett syndrome will be evaluated. Each patient will be self-contr…
Phase: PHASE1 • Sponsor: Unravel Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Bladder thermometer may boost brain bleed recovery
Disease control Recruiting nowThe goal of this clinical trial is to learn whether a bladder temperature monitoring-guided targeted temperature management (TTM) strategy improves functional recovery in patients with severe intracerebral hemorrhage, compared to conventional temperature monitoring. It will also …
Phase: NA • Sponsor: Yanyan Gong • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Can we find the perfect recipe to heal childhood trauma?
Symptom relief Recruiting nowThe goal of this clinical trial is to test the extent to which different treatment components work to improve pediatric post-traumatic stress disorder (PTSD). It will also provide evidence for how these components work. The main research questions are: What are the effects of di…
Phase: NA • Sponsor: University of Rochester • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Lab-Grown Mini-Tumors could predict best prostate cancer therapy
Knowledge-focused Recruiting nowFor men with an aggressive form of prostate cancer, finding the right and effective treatment right away is challenging. Many of these men face a high risk of cancer recurrence: about half experience a relapse after surgery, and more than a third after undergoing radiation therap…
Sponsor: Maastricht Radiation Oncology • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New hope for rare brain fungus: experimental drug olorofim tested
Disease control Not yet recruitingThis research study is being conducted to learn more about the use of olorofim in Coccidioidal (Cocci) meningitis, a rare but serious fungal infection that affects the brain and spinal cord. The study is exploratory, meaning that early information is being gathered to better unde…
Phase: PHASE2 • Sponsor: Fariba Donovan • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Could stem cell 'Messages' help repair scarred livers?
Disease control Not yet recruitingThis study Phase 1 clinical trial aimed to evaluate the safety and preliminary efficacy of intravenously administered extracellular vesicles derived from umbilical cord mesenchymal stem cells (UC-MSC-EVs; VinEV-3) in patients with liver cirrhosis. The trial uses a rolling six dos…
Phase: PHASE1 • Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Engineered immune cells take on rare sarcomas in early trial
Disease control Recruiting nowRATIONALE: MAGE-A4 is a cancer-testis antigen widely expressed in various mesenchymal tumors but absent in normal tissues, making it an ideal immunotherapeutic target. Given the limited effectiveness of conventional therapies in advanced mesenchymal tumors, this study seeks to ex…
Phase: PHASE1 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Mind reading? scientists decode imagined chinese speech from brain activity
Knowledge-focused Recruiting nowThe goal of this study is to investigate whether high-density electrocorticography (ECoG) signals recorded from the surface of the brain can be used to decode neural representations of Mandarin Chinese speech features, including lexical tone, without requiring overt speech moveme…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Summer camp aims to boost strength in kids with SMA
Disease control Recruiting nowThis single-arm pilot study will assess the preliminary effectiveness of an intensive motor skill intervention (HABIT-ILE) combined with functional strength training (FST) in children with SMA who are receiving disease-modifying therapies. Participants will attend a HABIT-ILE + F…
Phase: NA • Sponsor: Teachers College, Columbia University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New pain relief method could cut opioid use for war wounded
Symptom relief Not yet recruitingTo compare the effectiveness of continuous regional anaesthesia with standard pain management strategies for the treatment of acute pain in patients with war-related lower limb trauma.
Sponsor: Charitable Organisation Charitable Fund Superhumans (Co Cf Superhumans) • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
New blood test aims to cut unnecessary prostate biopsies
Diagnosis Not yet recruitingThis prospective observational study will enroll men referred for prostate biopsy due to elevated PSA and/or abnormal digital rectal examination, with or without pre-biopsy MRI. Peripheral blood will be collected prior to biopsy for PROSTest analysis. Biopsy histopathology will s…
Sponsor: Wren Laboratories LLC • Aim: Diagnosis
Last updated Jun 27, 2026 09:11 UTC
-
New trial aims to end surgery for rare breast disease
Disease control Not yet recruitingThe goal of this clinical trial is to find the most effective and safe medical treatment for Granulomatous Lobular Mastitis (GLM) - a rare, chronic inflammatory breast disease that affects young and middle-aged women, often following childbirth. The main questions it aims to ans…
Phase: PHASE1, PHASE2 • Sponsor: All India Institute of Medical Sciences, Bhubaneswar • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Robot vs. visual training: which boosts stroke recovery more?
Symptom relief Recruiting nowStroke frequently leads to balance impairment and gait dysfunction, increasing fall risk and limiting functional independence. Technology-assisted rehabilitation approaches such as robot-assisted gait training and visual feedback balance training have been shown to improve balanc…
Phase: NA • Sponsor: Abant Izzet Baysal University • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Nurse-Led protocol aims to cut radiation interruptions in head and neck cancer
Symptom relief Recruiting nowThe aim of this study is to investigate whether a nurse-led preemptive symptom management protocol can reduce the radiation therapy interruption rate in patients with head and neck cancer compared to conventional care models.
Phase: PHASE3 • Sponsor: West China Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
New heart valve fix without open surgery under Real-World watch
Disease control Not yet recruitingPost-market registry for post-market surveillance, as part of the post-market plan, for the HighLife transcatheter, transseptal, mitral valve replacement system in a real world commercial setting.
Sponsor: HighLife SAS • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New scoring system could cut Post-Transplant infections
Disease control Not yet recruitingWith the increasing use of letermovir and considering that haploidentical hematopoietic stem cell transplantation (haplo-HSCT) predominates in China alongside a high CMV seroprevalence in the population, multiple domestic centers have reported cases of CMV infection after letermo…
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Old gout drug could help curb alcohol cravings, new trial suggests
Disease control Recruiting nowThis study proposes a 16-week, between-subject, double-blind, randomized controlled trial (RCT) with probenecid (2g /day) compared to placebo in individuals with AUD to test if reduces craving and alcohol consumption.
Phase: PHASE2 • Sponsor: Brown University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New drug may cut transfusions for stem cell transplant patients
Disease control Not yet recruitingThis study aims to evaluate whether luspatercept can improve the efficacy and safety of anemia treatment in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation.
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Heart hole repair without X-Rays: major trial launches
Disease control Not yet recruitingAtrial septal defect (ASD) is a common congenital heart disease, and percutaneous interventional therapy is the main and effective treatment. Traditional percutaneous closure procedures are performed under fluoroscopic guidance and require contrast agents. A retrospective analysi…
Phase: PHASE4 • Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC